• HOME
  • LEADERSHIP
  • TECHNOLOGY
  • PUBLICATIONS
  • CONTACT
Lobesity Pharmaceuticals and Technologies Lobesity Pharmaceuticals and Technologies
  • HOME
  • LEADERSHIP
  • TECHNOLOGY
  • PUBLICATIONS
  • CONTACT

OUR MISSION: DEVELOPMENT OF INNOVATIVE THERAPIES TO TREAT OBESITY AND OTHER RELATED DISORDERS

MEET THE TEAM MAKING IT HAPPEN

Dan Lewis B&W

Daniel K. Lewis, MA

CHIEF EXECUTIVE OFFICER

M Michael Wolfe MD
Co-Founder & Chief Medical Officer

M Michael Wolfe MD

CO-FOUNDER & CHIEF MEDICAL OFFICER

Michael O Boylan PhD
Co-Founder & Chief Scientific Officer

Michael O Boylan PhD

CO-FOUNDER & CHIEF SCIENTIFIC OFFICER

Kim Berger Chief Financial Officer

Kim Berger

CHIEF FINANCIAL OFFICER

“Prior to 1990, not one state in the US had an obesity rate greater than 15%. By 2012, not one state had an obesity rate less than 20%. Furthermore, a 2014 study from the McKinsey Global Institute found that obesity and other related disorders costs the US economy $663 billion annually.”

 – Daniel K.Lewis, MA, Lobesity Chief Executive Officer

Contact Us

Thank you for your inquiry. How can we help you today?

Send Message
Lobesity blocks obesity at its roots because we realize the importance of first understanding how obesity occurs Contact Us

© 2021 · Lobesity LLC All Rights Reserved.